XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.25.2

Reverse Recapitalization and Pre-Closing Financing | 6 Months Ended
--- | ---
Jun. 30, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] |
Reverse Recapitalization and Pre-Closing Financing | 3. Reverse Recapitalization and Pre-Closing Financing As described within the Reverse Recapitalization and Pre-Closing Financing section in Note 1, on June 13, 2025, the reverse recapitalization between Pre-Merger Crescent and GlycoMimetics was consummated. The Merger was accounted for as a reverse recapitalization in accordance with U.S. GAAP. At the effective time of the Merger, substantially all of the assets of GlycoMimetics consisted of cash and other nominal non-operating assets and liabilities. No goodwill or intangible assets were recognized. As part of the recapitalization, the Company acquired the assets and liabilities listed below (in thousands):

X
- Definition Reverse Recapitalization And Pre-Closing Financing + References No definition available. + Details
Name: | cbio_ReverseRecapitalizationAndPreClosingFinancingTextBlock
Namespace Prefix: | cbio_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationAndAssetAcquisitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration